Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
Year: 2015
Type: article
Abstract: Acquired resistance to Hedgehog pathway inhibitors has been reported in the clinical setting and upregulation of noncanonical Hedgehog signaling is one of the major underlying mechanisms behind this resistance. As demonstrated in our recent study, greater clinical efficacy might be achieved by focusing on downstream targets of the chemokine-activated noncanonical Hedgehog signaling pathway such as BCAR4 and phospho-GLI2 (Ser149).
Source: Molecular & Cellular Oncology
Authors: Zhen Xing, Chunru Lin, Liuqing Yang
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $1,590
OpenAlex ID: W1567493360
